Natco Pharma Limited (NATCOPHARM) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.138x

Based on the latest financial reports, Natco Pharma Limited (NATCOPHARM) has a cash flow conversion efficiency ratio of 0.138x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs11.91 Billion ≈ $128.76 Million USD) by net assets (Rs86.54 Billion ≈ $935.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Natco Pharma Limited for the company's overall valuation and market capitalisation.

Natco Pharma Limited - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Natco Pharma Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Natco Pharma Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Natco Pharma Limited ranked by their cash flow conversion efficiency. Explore NATCOPHARM operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Atrium Ljungberg AB (publ)
ST:ATRLJ-B
0.005x
Fujian Kuncai Material Tech
SHG:603826
0.061x
Xintai Ntrl Gas
SHG:603393
0.044x
NP3 Fastigheter AB
ST:NP3
0.016x
China Eastern Airlines Corporation Limited
F:CIAH
0.231x
Flight Centre Travel Group Ltd
AU:FLT
-0.051x
Beijing Caishikou Department Store Co Ltd
SHG:605599
0.091x
BW Energy Ltd
OL:BWE
0.315x

Annual Cash Flow Conversion Efficiency for Natco Pharma Limited (2005–2025)

The table below shows the annual cash flow conversion efficiency of Natco Pharma Limited from 2005 to 2025. View Natco Pharma Limited (NATCOPHARM) stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs76.12 Billion
≈ $823.24 Million
Rs16.97 Billion
≈ $183.50 Million
0.223x +4.18%
2024-03-31 Rs58.53 Billion
≈ $632.99 Million
Rs12.52 Billion
≈ $135.43 Million
0.214x +130.24%
2023-03-31 Rs91.37 Billion
≈ $988.18 Million
Rs8.49 Billion
≈ $91.83 Million
0.093x +752.04%
2022-03-31 Rs42.64 Billion
≈ $461.09 Million
Rs465.00 Million
≈ $5.03 Million
0.011x -84.95%
2021-03-31 Rs41.23 Billion
≈ $445.93 Million
Rs2.99 Billion
≈ $32.31 Million
0.072x -34.28%
2020-03-31 Rs37.85 Billion
≈ $409.30 Million
Rs4.17 Billion
≈ $45.13 Million
0.110x -42.45%
2019-03-31 Rs34.91 Billion
≈ $377.54 Million
Rs6.69 Billion
≈ $72.33 Million
0.192x +27.11%
2018-03-31 Rs30.76 Billion
≈ $332.66 Million
Rs4.64 Billion
≈ $50.14 Million
0.151x -27.94%
2017-03-31 Rs16.53 Billion
≈ $178.81 Million
Rs3.46 Billion
≈ $37.40 Million
0.209x +166.23%
2016-03-31 Rs13.03 Billion
≈ $140.94 Million
Rs1.02 Billion
≈ $11.07 Million
0.079x -27.85%
2015-03-31 Rs8.51 Billion
≈ $92.04 Million
Rs926.66 Million
≈ $10.02 Million
0.109x -44.61%
2014-03-31 Rs7.33 Billion
≈ $79.24 Million
Rs1.44 Billion
≈ $15.58 Million
0.197x +74.77%
2013-03-31 Rs5.44 Billion
≈ $58.84 Million
Rs611.95 Million
≈ $6.62 Million
0.112x -18.24%
2012-03-31 Rs4.72 Billion
≈ $51.05 Million
Rs649.41 Million
≈ $7.02 Million
0.138x -28.06%
2011-03-31 Rs3.53 Billion
≈ $38.23 Million
Rs675.97 Million
≈ $7.31 Million
0.191x -23.21%
2010-03-31 Rs3.11 Billion
≈ $33.60 Million
Rs773.69 Million
≈ $8.37 Million
0.249x +77.24%
2009-03-31 Rs2.66 Billion
≈ $28.77 Million
Rs373.85 Million
≈ $4.04 Million
0.141x -34.64%
2008-03-31 Rs2.25 Billion
≈ $24.34 Million
Rs483.90 Million
≈ $5.23 Million
0.215x -11.13%
2007-03-31 Rs1.86 Billion
≈ $20.12 Million
Rs450.03 Million
≈ $4.87 Million
0.242x +19.35%
2006-03-31 Rs1.54 Billion
≈ $16.64 Million
Rs311.81 Million
≈ $3.37 Million
0.203x -52.96%
2005-03-31 Rs1.14 Billion
≈ $12.29 Million
Rs489.69 Million
≈ $5.30 Million
0.431x --

About Natco Pharma Limited

NSE:NATCOPHARM India Drug Manufacturers - Specialty & Generic
Market Cap
$1.59 Billion
Rs146.72 Billion INR
Market Cap Rank
#7021 Global
#336 in India
Share Price
Rs819.15
Change (1 day)
+0.47%
52-Week Range
Rs792.95 - Rs1206.00
All Time High
Rs1591.09
About

NATCO Pharma Limited, a pharmaceutical company, engages in the research and development, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; a… Read more